Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23208878 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults
Condition: Dengue
Intervention: Biological: Live attenuated tetravalent dengue vaccine

Indicates status has not been verified in more than two years